These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12373606)

  • 21. Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo.
    Shi XH; Liang ZY; Ren XY; Liu TH
    Cancer Gene Ther; 2009 Mar; 16(3):227-36. PubMed ID: 18949011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
    Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
    Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncolytic viral therapy for human pancreatic cancer cells by reovirus.
    Etoh T; Himeno Y; Matsumoto T; Aramaki M; Kawano K; Nishizono A; Kitano S
    Clin Cancer Res; 2003 Mar; 9(3):1218-23. PubMed ID: 12631628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense therapy specific to mutated K-ras gene in hamster pancreatic cancer model. Can it inhibit the growth of 5-FU and MMC-resistant metastatic and remetastatic cell lines?
    Morioka CY; Saito S; Machado MC; Ohzawa K; Kubrusly MS; Cunha JE; Watanabe A
    In Vivo; 2004; 18(2):113-7. PubMed ID: 15113037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
    Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
    Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of recombinant retroviral vector expressing antisense TGF alpha on malignant phenotype of human pancreatic carcinoma cell line.
    Xu Y; Liu T; Gao J
    Chin Med J (Engl); 1998 Apr; 111(4):334-8. PubMed ID: 10374398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation.
    Kato K; Ogura T; Kishimoto A; Minegishi Y; Nakajima N; Miyazaki M; Esumi H
    Oncogene; 2002 Sep; 21(39):6082-90. PubMed ID: 12203120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of the inhibitor of c-Met on the growth and motility of hepatocellular carcinoma cells].
    Chen BH; Xie Q; Liu KD
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):487-9. PubMed ID: 12939184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
    Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
    Jin K; Park S; Ewton DZ; Friedman E
    Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
    Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
    Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct.
    Georges RN; Mukhopadhyay T; Zhang Y; Yen N; Roth JA
    Cancer Res; 1993 Apr; 53(8):1743-6. PubMed ID: 8467490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrovirus mediated transfer of antisense human c-myc gene into human esophageal cancer cells suppressed cell proliferation and malignancy.
    Ye X; Wu M
    Sci China B; 1992 Jan; 35(1):76-83. PubMed ID: 1316126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of CTLs by DCs pulsed with K-ras mutant peptide on the surface of nanoparticles in the treatment of pancreatic cancer.
    Tan G; Wang Z; Zhang X; Cai Z; Zhang J
    Oncol Rep; 2011 Jul; 26(1):215-21. PubMed ID: 21573499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Reversal of malignant phenotype of human hepatoma cells by antisense c-ets-2, c-myc and N-ras].
    Huang XM; Wei SG; Wang LF
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):243-6. PubMed ID: 7805549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE.
    Zhou L; Jiang Y; Tan A; Greenlee AR; Shen Y; Liu L; Yang Q
    Toxicol Sci; 2008 Oct; 105(2):286-94. PubMed ID: 18567617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.